Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENUS I: Ulipristal Acetate for Uterine Fibroids
NCT02147197Phase 3Completed
- Sponsor
- Allergan
- Start
- Mar 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulipristal in Uterine Fibroids (UF), sponsored by Allergan. Started Mar 2014; status: completed.
02
Drugs
ulipristal
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02147197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147197.